cell culture

How Life Works: A User’s Guide to the New Biology

“Bold and intriguing.”—Wall Street Journal • “Penetrating. . . . Provocative and profound.”—Publishers Weekly (starred review) • “Offers plenty of food for thought.”—Kirkus Reviews (starred review)  “Ball’s marvelous book is both wide-ranging and deep. . . . I could not put it down.”—Siddhartha Mukherjee, author of The Song of the Cell and the Pulitzer Prize–winning The Emperor of All Maladies A new, cutting-edge vision of biology that revises our understanding of what life itself is, how to enhance it, and what possibilities it offers.   Biology is undergoing a quiet but profound transformation. Several aspects of the standard picture of how life works—the idea of the genome as a blueprint, of genes as instructions for building an organism, of proteins as precisely tailored molecular machines, of cells as entities with fixed identities, and more—have been exposed as incomplete, misleading, or wrong.   In How Life Works, Philip Ball explores the new biology, revealing life to be a far richer, more ingenious affair than we had guessed. Ball explains that there is no unique place to look for an answer to this question: life is a system of many levels—genes, proteins, cells, tissues, and body modules such as the immune system and the nervous system—each with its own rules and principles. How Life Works explains how these levels operate, interface, and work together (most of the time).   With this knowledge come new possibilities. Today we can redesign and reconfigure living systems, tissues, and organisms. We can reprogram cells, for instance, to carry out new tasks and grow into structures not seen in the natural world. As we discover the conditions that dictate the forms into which cells organize themselves, our ability to guide and select the outcomes becomes ever more extraordinary. Some researchers believe that ultimately we will be able to regenerate limbs and organs, and perhaps even create new life forms that evolution has never imagined.   Incorporating the latest research and insights, How Life Works is a sweeping journey into this new frontier of the life sciences, a realm that will reshape our understanding of life as we know it.

b.next: rebuilding biology for engineering

Rewilding cultures

Rewilding Cultures is a new step of Feral Labs Network. The project was initiated and si coordinated by Projekt Atol Institute (SI) in partnership with Schmiede (AT), Cultivamos Cultura (PT), Ionian University (GR), The Culture Yard (DK), Udruga Radiona (HR), Bioart Society (FI) and Makery.info (FR)

The evolving concept of cell identity in the single cell era

Summary: This Spotlight explores emerging technologies that are enabling the systematic and unbiased quantification of cell identity, and how these efforts will enable the construction of high-resolution, dynamic cell atlases.

Genspace

Genspace is the world’s first community biology lab—a place where anyone can learn and work on biotechnology.

For the First Time, a Cell Built From Scratch Grows and Divides | Quanta Magazine

Scientists built a synthetic cell that combines more lifelike properties than ever before — proof of concept that it’s possible to bring nonliving materials to life, or something close to it, in the lab.

For the First Time, a Cell Built From Scratch Grows and Divides | Quanta Magazine

Scientists built a synthetic cell that combines more lifelike properties than ever before — proof of concept that it’s possible to bring nonliving materials to life, or something close to it, in the lab.

How to understand cells, tissues and organisms as agents with agendas | Aeon Essays

Biology’s next great horizon is to understand cells, tissues and organisms as agents with agendas (even if unthinking ones)

On cell types and cell states

The advent of single-cell genomics has brought about new efforts to characterize and catalog all of the cell types in the human body. Despite these efforts, the very definition of a “cell type” is under debate. In this post, I will discuss a conceptual framework for defining cell types as subsets of states in an underlying cellular state space. Moreover, I will link the cellular state space to biomedical ontologies that attempt to capture biological knowledge regarding cell types.

Accelerating life sciences research

Discover how a specialized AI model, GPT-4b micro, helped OpenAI and Retro Bio engineer more effective proteins for stem cell therapy and longevity research.

Sleuths flag ‘complete mismatch’ in data of BMJ stem cell study | Manoj Lalu

This is disappointing, but I’m not surprised. I was one of the reviewers for the initial version. You can see by my review (it’s all open) that I flagged primary outcome switching, a complete lack of any data on the cells themselves, and sample size inconsistencies in the protocol versus the report (and within the report). The data seemed impressive. Too good to be true I guess? I never saw the paper again in peer review after that initial review. The next notification I received was that the paper was accepted. Given BMJ’s commitment to open peer review and post-publication scrutiny (which I admire), I have no doubt we will hear about a formal editorial investigation soon.

I’m going to cure my girlfriend’s brain tumor.

Launch of an experiment to use AI-Scientists to accelerate research of a "solved" disease.

Introducing Hypothesis commenting on bioRxiv and medRxiv: an updated way to engage with preprints - openRxiv

An important part of our mission at openRxiv is to collaborate with other organizations to improve science communication and promote interoperability. Preprints are just one part of the research workflow, and we want to ensure they are effectively integrated with the tools and communities that drive scientific progress. Today, we’re excited to share about another…

We live in a golden age of biology. So why are people still dying from disease? Because discovery and development move slower than they should. Today, we’re partnering with Incyte to change… | Samuel G. Rodriques | 491 comments

We live in a golden age of biology. So why are people still dying from disease? Because discovery and development move slower than they should. Today, we’re partnering with Incyte to change that. Kosmos is now the first agent that can compress months of drug development into weeks, from the earliest stages of scientific discovery through to FDA approval. Incyte will be the first company to deploy it across their pipeline. Work that used to take a team of scientists months now happens in weeks. Patients can't wait, and neither can we. | 491 comments on LinkedIn

Measuring AI’s capability to accelerate biological research in the wet lab

OpenAI introduces a real-world evaluation framework to measure how AI can accelerate biological research in the wet lab. Using GPT-5 to optimize a molecular cloning protocol, the work explores both the promise and risks of AI-assisted experimentation.